{"id":327740,"date":"2026-10-27T10:25:57","date_gmt":"2026-10-27T04:55:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/onesource-specl-pharma-l-q2-results-fy27-pat-57-crore\/"},"modified":"2026-10-27T10:25:57","modified_gmt":"2026-10-27T04:55:57","slug":"onesource-specl-pharma-l-q2-results-fy27-pat-57-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/onesource-specl-pharma-l-q2-results-fy27-pat-57-crore\/","title":{"rendered":"ONESOURCE SPECL PHARMA L Q2 Results FY27: PAT Jumps 447.95% to Rs 57.48 Cr, Revenue Rs 516.24 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

ONESOURCE SPECL PHARMA L<\/a> Q2 Results FY27 were declared on 27 October 2026, and the quarterly results show Consolidated revenue of Rs 516.24 Cr, up 37.39% YoY from Rs 375.76 Cr. Net profit reached Rs 57.48 Cr against Rs 10.49 Cr a year earlier, a rise of 447.95%. This YoY growth covers the July to September 2026 quarter.<\/p>\n<\/div>\n

ONESOURCE SPECL PHARMA L (ONESOURCE) Q2 Results FY27 announced on 27 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought Consolidated revenue of Rs 516.24 Cr and PAT of Rs 57.48 Cr, while ONESOURCE SPECL PHARMA L Q2 Results FY27 also show Operating Profit of Rs 163.29 Cr. These consolidated results compare the quarter with the same period of last year.<\/p>\n

This results analysis of ONESOURCE SPECL PHARMA L Q2 Results starts with the Financial Highlights table and then covers the key takeaways, business drivers, outlook and risks. Univest readers can use the figures below to place the quarter against the same quarter of the previous year, beginning with the table that sets revenue, Operating Profit and net profit side by side.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n